Mycoplasma Testing Market Report 2026

Mycoplasma Testing Market Overview

• Mycoplasma Testing market size has reached to $1.23 billion in 2025 • Expected to grow to $2.1 billion in 2030 at a compound annual growth rate (CAGR) of 11.1% • Growth Driver: Rising Incidence Of Mycoplasma Pneumonia Fuels Growth In Mycoplasma Testing Market • Market Trend: Digital PCR Kits Transform Mycoplasma Testing Market • North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under Mycoplasma Testing Market?

The mycoplasma testing detects mycoplasma pneumoniae, which causes mycoplasma pneumonia. Mycoplasma pneumonia is a contagious respiratory infection that spreads easily through contact with respiratory fluids. It can cause epidemics. Mycoplasma testing includes a group of tests that measures antibodies in the blood produced in response to a mycoplasma infection and detects the microbe directly through detecting or culturing its genetic material (DNA) in a body sample. The main types of mycoplasma testing technologies include polymerase chain reaction (PCR), enzyme-linked immunosorbent assay (ELISA), enzymatic methods, and deoxyribonucleic acid (DNA) staining. Polymerase chain reaction (PCR) detects mycoplasma species using primers specific for mycoplasma DNA, usually mycoplasma 16S rRNA genes. Enzyme-linked immunosorbent assay (ELISA) detects the presence of mycoplasma using either antibodies, or labeled probes for the mycoplasma 16S rRNA genes. Enzymatic methods use a sample of the suspected cell culture which converts ADP to ATP using mycoplasmal enzymes. Deoxyribonucleic acid (DNA) staining detects the mycoplasma strain M. hyorhinis by growing a sample of suspected cell cultures with Vero cells, and staining the cells for DNA using a fluorescent dye. The different products in mycoplasma testing include instruments, assay, kits, and reagents. Mycoplasma testing is applied in cell line testing, virus testing, and end- of- production cell testing and is used by pharmaceutical & biotechnology companies, cell banks & laboratories, contract research organizations, academic research institutes.

What Is The Mycoplasma Testing Market Growth Forecast?

The mycoplasma testing market size is expected to see rapid growth in the next few years. It will grow to $2.1 billion in 2030 at a compound annual growth rate (CAGR) of 11.1%. The growth in the forecast period can be attributed to expansion of biopharmaceutical manufacturing, growth in cro outsourcing, increased investment in genomic testing, rising regulatory emphasis on contamination control, adoption of automated testing platforms. Major trends in the forecast period include growing adoption of pcr-based mycoplasma detection, increasing use of rapid test kits for cell culture screening, rising demand for automated mycoplasma detection systems, expansion of assay and reagent usage in biopharmaceutical production, higher need for mycoplasma testing in research and cro settings.

Global Mycoplasma Testing Market Segmentation

1) By Product: Instruments, Assay, Kits, Reagents 2) By Technology: PCR, Elisa, Enzymatic Methods, DNA Staining, Other Technologies 3) By Application: Cell Line Testing, Virus Testing, End- Of- Production Cell Testing 4) By End User: Pharmaceutical & Biotechnology Companies, Cell Banks And Laboratories, Contract Research Organizations, Academic Research Institutes Subsegments: 1) By Instruments: Mycoplasma Detection Systems, Automated Test Equipment, PCR Equipment 2) By Assay: Mycoplasma Assays, Qualitative Assays, Quantitative Assays 3) By Kits: Mycoplasma Detection Kits, Mycoplasma Testing Kits For Cell Cultures, Sample Preparation Kits 4) By Reagents: Nucleic Acid Reagents, Cell Culture Reagents, Staining Reagents

What Is The Driver Of The Mycoplasma Testing Market?

The increasing prevalence of mycoplasma pneumonia is expected to propel the growth of the mycoplasma testing market going forward. Mycoplasma pneumonia refers to a respiratory infection caused by the bacteria Mycoplasma pneumoniae. Mycoplasma testing plays a crucial role in diagnosing Mycoplasma pneumonia by detecting the presence of Mycoplasma pneumoniae bacteria in respiratory specimens, aiding in the timely and accurate identification of the infection for appropriate medical treatment and management. For instance, in December 2023, according to the Centers for Disease Control and Prevention, a US-based government agency An estimated 2 million cases of Mycoplasma pneumoniae infections occur each year in the United States. Therefore, the increasing prevalence of mycoplasma pneumonia is driving the growth of the mycoplasma testing industry.

Key Players In The Global Mycoplasma Testing Market

Major companies operating in the mycoplasma testing market are Merck KGaA, Thermo Fisher Scientific Inc., Agilent Technologies Inc., Lonza Group AG, Roche Diagnostics International AG, Charles River Laboratories International Inc., Nelson Laboratories Fairfield Inc., Creative Bioarray, Biological Industries Israel Beit Haemek Ltd., Biotools B & M Labs S.A, PromoCell GmbH, American Type Culture Collection, Bionique Testing Laboratories Inc., InvivoGen, Clongen Laboratories LLC, Norgen Biotek Corporation, Gen Bio Sciences (P) Ltd., GeneCopoeia Inc., Minerva Biolabs GmbH, Mycoplasma Experience, Savyon Diagnostics, ScienCell Research Laboratories Inc.

Global Mycoplasma Testing Market Trends and Insights

Major companies operating in the mycoplasma testing market are increasing their focus on introducing digital PCR kits to gain a competitive edge in the market. Digital PCR kits refer to molecular biology tools that enable the precise quantification and analysis of nucleic acids, such as DNA or RNA, by using a digital approach. For instance, in November 2023, QIAGEN, a Germany-based diagnostics company, launched three new QIAcuity digital PCR kits and updated software to expand the use of digital PCR applications in biopharmaceutical research and food safety. The new QIAcuity kits are designed to ensure precise quantification and are available in one, four, and eight-plate versions, with the one-plate version capable of processing up to 384 samples in an eight-hour shift. The QIAcuity Mycoplasma Quant Kit is one of the new kits launched, and it offers researchers an accurate and precise way to detect mycoplasma contaminants in all steps of research.

What Are Latest Mergers And Acquisitions In The Mycoplasma Testing Market?

In May 2024, bioMérieux S.A., a France-based biotechnology company, announced partnership with AnaBioTec. Through this partnership, bioMérieux S.A. aims to seeks advance Mycoplasma testing methodologies, addressing the limitations of traditional methods that often require lengthy processing times (up to 28 days) and are unsuitable for the fast-paced biopharma environment. AnaBioTec is a Belgian-based analytical service provider for mycoplasma testing.

Regional Outlook

North America was the largest region in the mycoplasma testing market in 2025. Asia-Pacific is expected to be the fastest growing region in the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Mycoplasma Testing Market?

The mycoplasma testing market includes revenues earned by entities by PCR detection assay, indirect hoechst stain, and culture isolation. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Mycoplasma Testing Market Report 2026?

The mycoplasma testing market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the mycoplasma testing industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.